Kodiak Sciences Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2017 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Kodiak Sciences Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2017 to Q2 2024.
Kodiak Sciences Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $18.4M, a 28.8% decline year-over-year.
Kodiak Sciences Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $73.6M, a 29.1% decline year-over-year.
Kodiak Sciences Inc. annual Share-based Payment Arrangement, Expense for 2023 was $88.6M, a 16.5% decline from 2022.
Kodiak Sciences Inc. annual Share-based Payment Arrangement, Expense for 2022 was $106M, a 72.7% increase from 2021.
Kodiak Sciences Inc. annual Share-based Payment Arrangement, Expense for 2021 was $61.4M, a 100% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$73.6M	$18.4M	-$7.43M	-28.8%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$81M	$18.4M	-$7.57M	-29.1%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$88.6M	$22.8M	-$2.95M	-11.4%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-28
Q3 2023	$91.5M	$13.9M	-$12.2M	-46.7%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$104M	$25.8M	-$177K	-0.68%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-14
Q1 2023	$104M	$26M	-$2.12M	-7.53%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-15
Q4 2022	$106M	$25.8M	-$2.22M	-7.92%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$108M	$26.2M	+$13.8M	+112%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-14
Q2 2022	$94.4M	$26M	+$14.9M	+134%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	$79.6M	$28.1M	+$18.2M	+183%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	$61.4M	$28M	+$18.5M	+196%	Oct 1, 2021	Dec 31, 2021	10-K	2024-03-28
Q3 2021	$42.8M	$12.4M	+$4.14M	+50.2%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-09
Q2 2021	$38.7M	$11.1M	+$4.2M	+60.9%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	$34.5M	$9.93M	+$3.84M	+63.2%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	$30.7M	$9.46M	+$7.52M	+388%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-28
Q3 2020	$23.1M	$8.24M	+$6.47M	+365%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-09
Q2 2020	$16.7M	$6.89M	+$5.65M	+454%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-09
Q1 2020	$11M	$6.08M	+$4.93M	+426%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-10
Q4 2019	$6.11M	$1.94M	+$877K	+82.8%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-01
Q3 2019	$5.23M	$1.77M	+$973K	+122%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-09
Q2 2019	$4.26M	$1.24M	+$587K	+89.3%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019	$3.67M	$1.16M	+$1.07M	+1158%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-11
Q4 2018	$2.61M	$1.06M			Oct 1, 2018	Dec 31, 2018	10-K	2021-03-01
Q3 2018		$800K	+$731K	+1059%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018		$657K			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-14
Q1 2018		$92K			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-15
Q3 2017		$69K			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-16

* An asterisk sign (*) next to the value indicates that the value is likely invalid.